Showing 441 - 460 results of 12,614 for search '"drug"', query time: 0.09s Refine Results
  1. 441
  2. 442
  3. 443
  4. 444

    Initial Drug Regimen for Active Tuberculosis Cases in Montreal, 1995-1998 by Paul Rivest, Terry N Tannenbaum

    Published 2001-01-01
    “…OBJECTIVES: To evaluate the proportion of tuberculosis (TB) cases initially treated with the recommended four-drug regimen of isoniazid (INH), rifampin (RIF), pyrazinamide (PZA) and ethambutol (EMB) or streptomycin; and to identify factors associated with the choice of initial therapy.…”
    Get full text
    Article
  5. 445
  6. 446
  7. 447
  8. 448

    Applications of cell penetrating peptide-based drug delivery system in immunotherapy by Jing-Jing Du, Ru-Yan Zhang, Shangchi Jiang, Shanshan Xiao, Yiting Liu, Yongheng Niu, Wen-Xiang Zhao, Dongyuan Wang, Dongyuan Wang, XianShi Ma

    Published 2025-01-01
    “…This review presented a new insight into CPPs for drug delivery, which could provide advice on the design of clinically effective systemic delivery systems using CPPs.…”
    Get full text
    Article
  9. 449
  10. 450
  11. 451
  12. 452

    Hexapeptide dalargin in clinical gastroenterology: 30 years' of clinical application of the drug by S. A. Bulgakov

    Published 2016-08-01
    “…To discuss results of application of the Russian drug dalargin in the treatment of gastroenterological diseases. …”
    Get full text
    Article
  13. 453

    The Problem of Confounding in Studies of the Effect of Maternal Drug Use on Pregnancy Outcome by Bengt Källén

    Published 2012-01-01
    “…Confounding by concomitant maternal drug use may occur. A geographical or seasonal confounding can exist. …”
    Get full text
    Article
  14. 454

    Nanotherapeutics for Meningitis: Enhancing Drug Delivery Across the Blood-Brain Barrier by Hitaishi Sharma, Kannan Badri Narayanan, Shampa Ghosh, Krishna Kumar Singh, Prarthana Rehan, Aparajita Dasgupta Amist, Rakesh Bhaskar, Jitendra Kumar Sinha

    Published 2025-01-01
    “…Meningitis is the acute or chronic inflammation of the protective membranes, surrounding the brain and spinal cord, and this inflammatory process spreads throughout the subarachnoid space. The traditional drug delivery methods pose a disadvantage in limiting the capacity of crossing the blood–brain barrier (BBB) to reach the central nervous system (CNS). …”
    Get full text
    Article
  15. 455

    Flunarizine as a Candidate for Drug Repurposing Against Human Pathogenic Mammarenaviruses by Chukwudi A. Ofodile, Ikemefuna C. Uzochukwu, Fortunatus C. Ezebuo, InnocentMary Ejiofor, Mercy Adebola, Innocent Okpoli, Beatrice Cubitt, Haydar Witwit, Chetachi B. Okwuanaso, Ngozi Onyemelukwe, Juan Carlos de la Torre

    Published 2025-01-01
    “…Flunarizine is being used in several countries worldwide to treat vertigo and migraine, supporting the interest in exploring its repurposing as a candidate drug to treat LASV infections.…”
    Get full text
    Article
  16. 456
  17. 457
  18. 458

    Therapeutic Drug Monitoring of Meropenem in Neonate with Necrotizing Enterocolitis: A Challenge by Steven De Keukeleire, Daniëlle Borrey, Wim Decaluwe, Marijke Reynders

    Published 2016-01-01
    “…We describe the added value of therapeutic drug monitoring by presenting the case of a preterm infant with severe NEC treated with meropenem. …”
    Get full text
    Article
  19. 459
  20. 460

    Drug Repositioning for Gynecologic Tumors: A New Therapeutic Strategy for Cancer by Kouji Banno, Miho Iida, Megumi Yanokura, Haruko Irie, Kenta Masuda, Yusuke Kobayashi, Eiichiro Tominaga, Daisuke Aoki

    Published 2015-01-01
    “…The goals of drug repositioning are to find a new pharmacological effect of a drug for which human safety and pharmacokinetics are established and to expand the therapeutic range of the drug to another disease. …”
    Get full text
    Article